July 6, 2018

Please reload

Recent Posts

FDA Comments on Recently Released Rare Disease Guidance for Industry

September 16, 2015

Jonathan Goldsmith, M.D., F.A.C.P., FDA’s Associate Director, Rare Diseases Program, Center for Drug Evaluation and Research, comments on the recently...

Please reload

Featured Posts

Recent Budget Approval Increases Funding Across Nearly All US Science Agencies

April 9, 2018

In March, the President signed the 2018 legislation that increased the budget for nearly all US science agencies, a $1.3 trillion spending deal.  This boosted funding for the National Institutes of Health (NIH) to a historic high of $37 billion, an increase of $3 billion over the 2017 levels. 


Additionally, the US Food and Drug Administration's (FDA) budget increases to a total of $2.9 billion in discretionary funding, $135 million above the 2017 enacted level, according to the House Appropriations Committee.


As reported by Science Magazine, the increases were made possible, in large part, by an agreement reached earlier this year to raise mandatory caps on civilian and military spending that gave lawmakers an additional $300 billion to spend this year and next. 


For further information and details of the budget appropriations, please read the following article: http://www.sciencemag.org/news/2018/03/updated-us-spending-deal-contains-largest-research-spending-increase-decade





Please reload

Patagonia Pharmaceuticals, LLC

50 Tice Blvd, Suite A26

Woodcliff Lake, NJ 07677

For more info: info@patagoniarx.com

© 2019 by Patagonia Pharmaceuticals, LLC